Ascendis Pharma develops drugs for endocrinology, central nervous system disorders and infectious diseases.
Business Model:
Revenue: $4.7M
Employees: 201-500
Address: Tuborg Boulevard 5
City: Hellerup
State: other
Zip: 2900
Country: DK
Ascendis Pharma develops drugs for endocrinology, central nervous system disorders and infectious diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
1/28/2015
IPO Valuation:
$373M
Ticker Symbol:
ASND
IPO Price:
$18/share
Amount Raised:
$108M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2021 | Visen Pharmaceuticals | Series B | 0 |
11/2018 | Visen Pharmaceuticals | Series A | 0 |
1/2021 | Visen Pharmaceuticals | Series B | 0 |
11/2018 | Visen Pharmaceuticals | Series A | 0 |
Announced Date | Name | Price |
---|---|---|
12/2007 | Complex Biosystems |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|